Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model

Front Immunol. 2018 Jul 24:9:1719. doi: 10.3389/fimmu.2018.01719. eCollection 2018.

Sharon Wei Ling Lee^{1

2

3}, Giulia Adriani¹, Erica Ceccarello^{2

4}, Andrea Pavesi⁴, Anthony Tanoto Tan⁵, Antonio Bertoletti⁵, Roger Dale Kamm^{1

6}, Siew Cheng Wong^{2

3}

¹ BioSystems and Micromechanics IRG, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore.
² Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
³ Singapore Immunology Network (SIgN), Biomedical Sciences Institute, Agency for Science, Technology, and Research, Singapore, Singapore.
⁴ Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research, Singapore, Singapore.
⁵ Programme of Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
⁶ Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2018.00416.].

Keywords: PD-L1; T cell receptor-redirected T cells; immune checkpoint; immunotherapy; microfluidics; monocytes; tumor microenvironment.